| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918794 | Radiotherapy and Oncology | 2013 | 5 Pages |
Abstract
Although SABR was second choice after PME, survival after PME was not better than after SABR. Prospective comparative studies are clearly required to define the role of both, SABR and PME in OMD.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Joachim Widder, Theo J. Klinkenberg, Jan F. Ubbels, Erwin M. Wiegman, Harry J.M. Groen, Johannes A. Langendijk,